Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1
暂无分享,去创建一个
M. Martínez-Lorenzo | A. Anel | I. Monleón | A. Piñeiro | J. Naval | M. Alava | L. Larrad | P. Lasierra | L. Monteagudo | M. Taulés | M. Iturralde
[1] P. Ricciardi-Castagnoli,et al. Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.
[2] E. Nabel,et al. Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity , 2001, Nature Immunology.
[3] P. Möller,et al. CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies , 2001, Cell Death and Differentiation.
[4] R. Siegel,et al. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity , 2000, Nature Immunology.
[5] H. Geuze,et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.
[6] L. Page,et al. Sorting out the multiple roles of Fas ligand. , 2000, European journal of cell biology.
[7] J K Frederiksen,et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. , 2000, Science.
[8] P. Golstein. FasL Binds Preassembled Fas , 2000, Science.
[9] B. Hoflack,et al. Bi-directional trafficking between the trans-Golgi network and the endosomal/lysosomal system. , 2000, Journal of cell science.
[10] S. Ju,et al. Bioactivities of Fas Ligand-Expressing Retroviral Particles1 , 2000, The Journal of Immunology.
[11] L. Mincheva-Nilsson,et al. gammadelta T cells of human early pregnancy decidua: evidence for cytotoxic potency. , 2000, International immunology.
[12] M. Martínez-Lorenzo,et al. CD59 cross‐linking induces secretion of APO2 ligand in overactivated human T cells , 2000, European journal of immunology.
[13] P. Krammer,et al. Tumor counterattack – concept and reality , 2000, European journal of immunology.
[14] Laurence Zitvogel,et al. Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.
[15] M. Martínez-Lorenzo,et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. , 1999, Journal of immunology.
[16] K. Iwabuchi,et al. Chemotactic activity of soluble Fas ligand against phagocytes. , 1998, Journal of immunology.
[17] M. Martínez-Lorenzo,et al. Involvement of APO2 ligand/TRAIL in activation‐induced death of Jurkat and human peripheral blood T cells , 1998, European journal of immunology.
[18] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[19] H. Geuze,et al. Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.
[20] J. Tschopp,et al. Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.
[21] S. Nagata,et al. Downregulation of Fas ligand by shedding , 1998, Nature Medicine.
[22] T. Ochi,et al. Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.
[23] M. Hanani,et al. Immunoreactivity for the Fas ligand in the mammalian enteric nervous system , 1997, Cell and Tissue Research.
[24] K. Okumura,et al. Antitumor effect of locally produced CD95 ligand , 1997, Nature Medicine.
[25] M. Martínez-Lorenzo,et al. Release of preformed Fas ligand in soluble form is the major factor for activation‐induced death of Jurkat T cells , 1996, Immunology.
[26] S. Marsters,et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.
[27] S. Yonehara,et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.
[28] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[29] A. Kawasaki,et al. Metalloproteinase-mediated release of human Fas ligand , 1995, The Journal of experimental medicine.
[30] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[31] Masato Tanaka,et al. Expression of the functional soluble form of human fas ligand in activated lymphocytes. , 1995, The EMBO journal.
[32] P. Krammer,et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.
[33] S. Ju,et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation , 1995, Nature.
[34] Seamus J. Martin,et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas , 1995, Nature.
[35] C. Smith,et al. Fas ligand mediates activation-induced cell death in human T lymphocytes , 1995, The Journal of experimental medicine.
[36] P. Golstein,et al. T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A , 1994, European journal of immunology.
[37] J. Inazawa,et al. Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.
[38] A. Abbas,et al. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.
[39] P. Golstein,et al. Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? , 1994, European journal of immunology.
[40] Peter J. Peters. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes , 1991, The Journal of experimental medicine.
[41] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[42] G. Griffiths,et al. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells , 1999, Nature Medicine.
[43] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[44] M. Shannon,et al. Lead and caries , 1998, Nature Medicine.
[45] P. Ehrlich. Granules of the Human Neutrophilic Polymorphonuclear Leukocyte , 1997 .
[46] J. Russell,et al. Activation-induced death of mature T cells in the regulation of immune responses. , 1995, Current opinion in immunology.
[47] E. Kellenberger,et al. Low-Temperature Embedding , 1986 .